Alentis Therapeutics
SwitzerlandEntry
2021
Hold
5yr
Status
Active
Who owns Alentis Therapeutics?
Alentis Therapeutics is currently owned by Jeito Capital through Jeito I (2021 vintage), since 2021. Across its history, Alentis Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
Jeito CapitalActive
2021 · present(5yr) · Jeito I · 2021 · VC
Novo HoldingsActive
2023 · present(3yr) · Novo Holdings Venture Investments · 1999 · VC
More from Jeito I
Other portfolio companies in the same fund.
France
Spain
Germany
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Alentis Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Alentis Therapeutics?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Alentis Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue